Patents expiring in 2028

US 7361665

Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361350

Use of an IL-1 antagonist for treating arthritis

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361332

Treating tumors using implants comprising combinations of allogeneic cells

The Regents of the University of California · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361476

Methionyl tRNA synthetase polynucleotides

Replidyne, Inc. · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361504

Culturing Anaplasma

Regents of the University of Minnesota · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361356

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361646

Methods for treating gastroesophageal reflux disease

Corcept Therapeutics Incorporated · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361664

Vitamin D receptor antagonists and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361671

Substituted heteroarylalkanoic acids

The Institute for Pharmaceutical Discovery, LLC · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361752

RNAi modulation of MLL-AF4 and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361680

Indole compounds useful for the treatment of cancer

The Regents of the University of California · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361756

Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7364719

Vasoregulating compounds and methods of their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7365165

IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7364726

Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine

The Regents of the University of California · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7365047

Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

The Regents of the University of California · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7365050

Methods for modulating a drug-related effect or behavior

The Regents of the University of California · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7365096

Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

The Board of Regents of the University of Texas System · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7365072

Inhibitors of p38

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7365092

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7365171

Chemokine-like factors (CKLFs) with chemotactic and hematopoietic stimulating activities

Beijing Medical University United Biological Engineering Company · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7365175

Wit 3.0, a novel gene to control soft tissue wound healing

The Regents of the University of California · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368275

In vivo incorporation of unnatural amino acids

The Regents of the University of California · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368116

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368452

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368106

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368110

Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368463

Substituted 4-amino-1-benzylpiperidine compounds

Theravance, Inc. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368100

Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368114

Fusion protein including of CD4

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368435

Topical endoparasiticide and ectoparasiticide formulations

Summit VetPharm, LLC · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368102

Pulmonary delivery of aminoglycosides

Nektar Therapeutics · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368232

High-throughput assay for virus entry and drug screening

The Board of Regents of the University of Texas System · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368279

Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368468

Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368257

Modulators of lymphocyte activation, Mkk3b compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368578

Five-membered heterocyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368606

Amorphous cinacalcet hydrochloride and preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368534

Myostatin and mimetics thereof

ORICO LIMITED · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371572

Mouse titers after two immunizations with VLPs alone

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371385

Method of treating immune pathologies with low dose estrogen

Government of the United states of America dba The Department of Veterans Affairs · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371821

Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371364

Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

The Board of Regents of the University of Texas System · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371372

Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection

Vertex Pharmaceuticals Incorporated · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371403

Wound dressing and method for controlling severe, life-threatening bleeding

Providence Health System—Oregon · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371392

Cd40 ligand adjuvant for respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371225

Method for convection enhanced delivery of therapeutic agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7371571

Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore

BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)